Nalaganje...

A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals

Ebola virus (EBOV) causes a severe hemorrhagic fever with case fatality rates of up to 90%, for which no antiviral therapies are available. Antiviral screening is hampered by the fact that development of cytopathic effect, the easiest means to detect infection with wild-type EBOV, is relatively slow...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Hoenen, Thomas, Groseth, Allison, Callison, Julie, Takada, Ayato, Feldmann, Heinz
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3787978/
https://ncbi.nlm.nih.gov/pubmed/23751367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2013.05.017
Oznake: Označite
Brez oznak, prvi označite!